ERYTHROMYCIN ETHYL SUCCINATE MICRONIZED

Erythromycin ethylsuccinate is a palatable macrolide formulation for pediatric use. Side effects include GI discomfort and rare allergic reactions. Only GMP materials will be supplied, logistics all according to GDP.

SKU: e98dca44c00d Category: Tag:

Product Description


Mechanism of Action

Erythromycin ethyl succinate is an acidstable ester prodrug that converts to active erythromycin after absorption. Micronization enhances dissolution in gastrointestinal environments, improving systemic availability.

Benefits and Advantages

Used in prodrugactivation research, macrolidebioavailability modelling, ribosomalbinding studies, and pediatricformulation development.

Side Effects and Risks

Risks include GI intolerance, transient liver enzyme elevation and rare hypersensitivity. Handle with estermacrolide precautions.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C43H75NO16

Molecular Weight

869.0 g/mol

CAS Number

1264-62-6

Storage Condition

Store in a cool, dry place; protect from light

Solubility

Soluble in water

Purity

Purity information is available upon request (COA).

Synonym

methanol; methyl alcohol; 67-56-1; wood alcohol; Wood naphtha

IUPAC/Chemical Name

Ethyl succinate ester of erythromycin

InChl Key

Unavailable

InChl Code

Unavailable

References

PubChem; ChemBL; FDA;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download